BCL2A1 and autoimmune disease: GAS5 interacts with the DNA binding domain of glucocorticoid receptors (GRs), and preventing GRs from connecting with DNA, preventing glucocorticoid activity which is a powerful immunosuppressive and hence contributes to the development of autoimmune disorders (Moharamoghli et al., 2019).